To Receive our
   Newsletters please
   enter your Email:


     


  Welcome to Drug Safety Institute

  Drug Safety Institute, a subsidiary of Brand Institute, provides proprietary and   nonproprietary name safety testing, risk management strategies, and regulatory   submission guidance for pharmaceutical, biotechnology, and healthcare device   manufacturers. In addition, Drug Safety Institute provides medication error   prevention analysis for new product labels and packaging.

Learn More     


  Related Links

  - FDA
  - FDA MedWatch
  - FDA (AERS)
  - USP
  - Health Canada
  - EMEA
  - NCC MERP
 

Related Articles

Brand Name Analysis
Drug Experts
Drug Labeling 1
Drug Labeling 2
Drug Labeling 3
Drug Labeling 4
Drug Name Review
Drug Packaging
Drug Packaging 2
Drug Safety
Drug Safety 2
Effect Analysis
FDA Report
FMEA
FMEA
Generic Drugs
Health Canada Report
Health Canada Report
Look Alike
Medication Safety
Medication Error
Medication Error
Post-marketing Risk Assessment
Risk Minimization
Safe Medication Practices
Stigmatized Diseases

More Articles

Screener Participation

Click Here To Continue

 Home  |  About Us  |  Proprietary Naming  |  NonProprietary Naming  |  Labeling & Packaging  |  Risk Management  |   News  |  Contact Us
  Copyright © 2005 Drug Safety Institute. All Rights Reserved.